JPMorgan lowered the firm’s price target on Illumina (ILMN) to $85 from $120 and keeps a Neutral rating on the shares. The firm says that despite the solid Q1 results, the dynamic tariff environment, uncertainty on U.S. academic funding, export restrictions into China as well as evolving competitive dynamics limit the company’s near-term visibility.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina’s Financial Outlook: Hold Rating Amidst Export Bans and Tariff Challenges
- Illumina Reports Q1 2025 Financial Results Amid Challenges
- Closing Bell Movers: Pinterest jumps 15%, Toast up 7% after earnings
- Illumina reports Q1 adjusted EPS 97c, consensus 94c
- Illumina cuts FY25 adjusted EPS view to $4.20-$4.30 from $4.50, consensus $4.46
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue